Intravenous Oxytocin for Recovery After Total Hip Replacement

This trial tests whether an IV treatment with oxytocin (a hormone given through an intravenous drip) can speed recovery after hip replacement surgery by increasing daily steps over eight weeks. The study compares oxytocin to a placebo to determine which is more effective. It seeks participants scheduled for a first-time hip replacement who are in overall good health. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group of people.

The trial requires that you stop taking certain medications, including thiazide diuretics, loop diuretics, lithium, and some antidepressants like SSRIs and MAOIs. If you're on any of these, you may need to stop them before participating.

Research has shown that intravenous oxytocin is generally safe for patients undergoing hip surgery. Studies have found that oxytocin, compared to a saltwater solution, does not increase the risk of low blood pressure or the need for medication to raise blood pressure. This suggests the treatment likely doesn't cause major heart or blood pressure issues. While these results are encouraging, it's important to note that the treatment is still under investigation for recovery after hip replacement surgery. Ongoing studies will provide more detailed safety information.¹²³⁴⁵

Unlike the standard treatments for recovery after total hip replacement, which typically focus on pain management and physical therapy, intravenous oxytocin offers a novel approach by potentially enhancing recovery through its unique mechanism of action. Oxytocin is a hormone known for its role in social bonding and childbirth, but it also has anti-inflammatory properties that could help reduce post-surgical inflammation and promote healing. Researchers are excited about this treatment because it targets recovery in a holistic way, potentially speeding up the process and improving overall outcomes by addressing both physical and inflammatory responses to surgery.

Research suggests that administering oxytocin through an IV might speed up recovery after hip surgery. In this trial, participants will receive either oxytocin or a placebo. Some studies have found that oxytocin can reduce pain and disability more quickly after surgery. For instance, patients who received oxytocin after hip replacement reported returning to their daily activities and moving around sooner. Although the evidence isn't definitive yet, these early results indicate that oxytocin could help patients resume their normal routines more quickly after surgery.²³⁴⁵⁶